nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—HTR6—Alzheimer's disease	0.227	0.514	CbGaD
Clomipramine—HTR2A—Donepezil—Alzheimer's disease	0.0923	0.338	CbGbCtD
Clomipramine—SLC6A4—Alzheimer's disease	0.0869	0.197	CbGaD
Clomipramine—HTR2A—Alzheimer's disease	0.0668	0.151	CbGaD
Clomipramine—CYP2D6—Alzheimer's disease	0.061	0.138	CbGaD
Clomipramine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0384	0.141	CbGbCtD
Clomipramine—CYP2C19—Memantine—Alzheimer's disease	0.035	0.128	CbGbCtD
Clomipramine—CYP2D6—Donepezil—Alzheimer's disease	0.0307	0.113	CbGbCtD
Clomipramine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0244	0.0895	CbGbCtD
Clomipramine—CYP2D6—Galantamine—Alzheimer's disease	0.0198	0.0725	CbGbCtD
Clomipramine—CYP3A4—Donepezil—Alzheimer's disease	0.0195	0.0716	CbGbCtD
Clomipramine—CYP3A4—Galantamine—Alzheimer's disease	0.0126	0.0461	CbGbCtD
Clomipramine—HTR2C—choroid plexus—Alzheimer's disease	0.00824	0.17	CbGeAlD
Clomipramine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00425	0.0877	CbGeAlD
Clomipramine—HTR2A—choroid plexus—Alzheimer's disease	0.00413	0.0853	CbGeAlD
Clomipramine—HTR2A—locus ceruleus—Alzheimer's disease	0.00255	0.0527	CbGeAlD
Clomipramine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00241	0.0498	CbGeAlD
Clomipramine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00208	0.043	CbGeAlD
Clomipramine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00121	0.025	CbGeAlD
Clomipramine—HTR6—forebrain—Alzheimer's disease	0.00109	0.0225	CbGeAlD
Clomipramine—HTR6—telencephalon—Alzheimer's disease	0.001	0.0207	CbGeAlD
Clomipramine—GSTP1—embryo—Alzheimer's disease	0.000812	0.0168	CbGeAlD
Clomipramine—GSTP1—forebrain—Alzheimer's disease	0.000718	0.0148	CbGeAlD
Clomipramine—GSTP1—telencephalon—Alzheimer's disease	0.00066	0.0136	CbGeAlD
Clomipramine—HTR2C—forebrain—Alzheimer's disease	0.000631	0.013	CbGeAlD
Clomipramine—HTR2A—blood vessel—Alzheimer's disease	0.0006	0.0124	CbGeAlD
Clomipramine—SLC6A4—forebrain—Alzheimer's disease	0.000598	0.0123	CbGeAlD
Clomipramine—HTR6—nervous system—Alzheimer's disease	0.000592	0.0122	CbGeAlD
Clomipramine—HTR2B—forebrain—Alzheimer's disease	0.000592	0.0122	CbGeAlD
Clomipramine—HTR2C—telencephalon—Alzheimer's disease	0.00058	0.012	CbGeAlD
Clomipramine—HTR6—central nervous system—Alzheimer's disease	0.00057	0.0118	CbGeAlD
Clomipramine—SLC6A4—telencephalon—Alzheimer's disease	0.00055	0.0113	CbGeAlD
Clomipramine—HTR2B—telencephalon—Alzheimer's disease	0.000545	0.0112	CbGeAlD
Clomipramine—HRH2—nervous system—Alzheimer's disease	0.000542	0.0112	CbGeAlD
Clomipramine—SLC6A2—forebrain—Alzheimer's disease	0.000526	0.0109	CbGeAlD
Clomipramine—HRH2—central nervous system—Alzheimer's disease	0.000521	0.0108	CbGeAlD
Clomipramine—Olopatadine—S100B—Alzheimer's disease	0.000506	0.128	CrCbGaD
Clomipramine—SLC6A2—telencephalon—Alzheimer's disease	0.000484	0.00999	CbGeAlD
Clomipramine—HTR6—brain—Alzheimer's disease	0.000453	0.00934	CbGeAlD
Clomipramine—HRH2—brain—Alzheimer's disease	0.000414	0.00854	CbGeAlD
Clomipramine—ABCB1—blood vessel—Alzheimer's disease	0.000393	0.00811	CbGeAlD
Clomipramine—GSTP1—nervous system—Alzheimer's disease	0.00039	0.00805	CbGeAlD
Clomipramine—GSTP1—central nervous system—Alzheimer's disease	0.000375	0.00775	CbGeAlD
Clomipramine—ADRA2A—forebrain—Alzheimer's disease	0.000372	0.00768	CbGeAlD
Clomipramine—GSTP1—cerebellum—Alzheimer's disease	0.000367	0.00757	CbGeAlD
Clomipramine—HTR2A—embryo—Alzheimer's disease	0.000358	0.00738	CbGeAlD
Clomipramine—HTR2C—nervous system—Alzheimer's disease	0.000342	0.00706	CbGeAlD
Clomipramine—ADRA2A—telencephalon—Alzheimer's disease	0.000342	0.00706	CbGeAlD
Clomipramine—HTR2C—central nervous system—Alzheimer's disease	0.00033	0.0068	CbGeAlD
Clomipramine—SLC6A4—nervous system—Alzheimer's disease	0.000324	0.0067	CbGeAlD
Clomipramine—HTR2B—nervous system—Alzheimer's disease	0.000322	0.00664	CbGeAlD
Clomipramine—HTR2A—forebrain—Alzheimer's disease	0.000316	0.00653	CbGeAlD
Clomipramine—SLC6A4—central nervous system—Alzheimer's disease	0.000312	0.00645	CbGeAlD
Clomipramine—HTR2B—central nervous system—Alzheimer's disease	0.00031	0.00639	CbGeAlD
Clomipramine—GSTP1—brain—Alzheimer's disease	0.000298	0.00615	CbGeAlD
Clomipramine—Dimetacrine—ACHE—Alzheimer's disease	0.000293	0.0739	CrCbGaD
Clomipramine—HTR2A—telencephalon—Alzheimer's disease	0.000291	0.006	CbGeAlD
Clomipramine—CYP2D6—forebrain—Alzheimer's disease	0.000288	0.00595	CbGeAlD
Clomipramine—SLC6A2—nervous system—Alzheimer's disease	0.000286	0.0059	CbGeAlD
Clomipramine—SLC6A2—central nervous system—Alzheimer's disease	0.000275	0.00568	CbGeAlD
Clomipramine—CYP2D6—telencephalon—Alzheimer's disease	0.000265	0.00547	CbGeAlD
Clomipramine—HTR2C—brain—Alzheimer's disease	0.000262	0.0054	CbGeAlD
Clomipramine—ALB—brain—Alzheimer's disease	0.000255	0.00527	CbGeAlD
Clomipramine—SLC6A4—brain—Alzheimer's disease	0.000248	0.00512	CbGeAlD
Clomipramine—HTR2B—brain—Alzheimer's disease	0.000246	0.00507	CbGeAlD
Clomipramine—ABCB1—embryo—Alzheimer's disease	0.000234	0.00484	CbGeAlD
Clomipramine—SLC6A2—brain—Alzheimer's disease	0.000218	0.00451	CbGeAlD
Clomipramine—ABCB1—forebrain—Alzheimer's disease	0.000207	0.00428	CbGeAlD
Clomipramine—ADRA2A—nervous system—Alzheimer's disease	0.000202	0.00417	CbGeAlD
Clomipramine—ADRA2A—central nervous system—Alzheimer's disease	0.000194	0.00401	CbGeAlD
Clomipramine—ABCB1—telencephalon—Alzheimer's disease	0.000191	0.00393	CbGeAlD
Clomipramine—ADRA2A—cerebellum—Alzheimer's disease	0.00019	0.00392	CbGeAlD
Clomipramine—Amitriptyline—NTRK2—Alzheimer's disease	0.000181	0.0456	CrCbGaD
Clomipramine—HTR2A—nervous system—Alzheimer's disease	0.000172	0.00354	CbGeAlD
Clomipramine—HTR2A—central nervous system—Alzheimer's disease	0.000165	0.00341	CbGeAlD
Clomipramine—HTR2A—cerebellum—Alzheimer's disease	0.000162	0.00333	CbGeAlD
Clomipramine—CYP3A4—nervous system—Alzheimer's disease	0.000159	0.00328	CbGeAlD
Clomipramine—CYP2D6—nervous system—Alzheimer's disease	0.000156	0.00323	CbGeAlD
Clomipramine—ADRA2A—brain—Alzheimer's disease	0.000154	0.00319	CbGeAlD
Clomipramine—CYP3A4—central nervous system—Alzheimer's disease	0.000153	0.00316	CbGeAlD
Clomipramine—CYP2D6—central nervous system—Alzheimer's disease	0.000151	0.00311	CbGeAlD
Clomipramine—CYP2D6—cerebellum—Alzheimer's disease	0.000147	0.00304	CbGeAlD
Clomipramine—HTR2A—brain—Alzheimer's disease	0.000131	0.00271	CbGeAlD
Clomipramine—Chlorprothixene—HTR6—Alzheimer's disease	0.00012	0.0302	CrCbGaD
Clomipramine—CYP2D6—brain—Alzheimer's disease	0.00012	0.00247	CbGeAlD
Clomipramine—Promethazine—CALM1—Alzheimer's disease	0.000118	0.0298	CrCbGaD
Clomipramine—Nortriptyline—HTR6—Alzheimer's disease	0.000117	0.0296	CrCbGaD
Clomipramine—Trifluoperazine—CALM1—Alzheimer's disease	0.000116	0.0294	CrCbGaD
Clomipramine—Perphenazine—CALM1—Alzheimer's disease	0.000115	0.0291	CrCbGaD
Clomipramine—Thioridazine—HTR6—Alzheimer's disease	0.000113	0.0286	CrCbGaD
Clomipramine—ABCB1—nervous system—Alzheimer's disease	0.000113	0.00232	CbGeAlD
Clomipramine—ABCB1—central nervous system—Alzheimer's disease	0.000108	0.00224	CbGeAlD
Clomipramine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000107	0.000588	CcSEcCtD
Clomipramine—Chills—Donepezil—Alzheimer's disease	0.000107	0.000587	CcSEcCtD
Clomipramine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000107	0.000587	CcSEcCtD
Clomipramine—Tachycardia—Galantamine—Alzheimer's disease	0.000106	0.000586	CcSEcCtD
Clomipramine—Arrhythmia—Donepezil—Alzheimer's disease	0.000106	0.000585	CcSEcCtD
Clomipramine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000106	0.000584	CcSEcCtD
Clomipramine—ABCB1—cerebellum—Alzheimer's disease	0.000106	0.00219	CbGeAlD
Clomipramine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000106	0.000583	CcSEcCtD
Clomipramine—Skin disorder—Galantamine—Alzheimer's disease	0.000106	0.000583	CcSEcCtD
Clomipramine—Urethral disorder—Memantine—Alzheimer's disease	0.000106	0.000583	CcSEcCtD
Clomipramine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000106	0.000581	CcSEcCtD
Clomipramine—Doxepin—HTR6—Alzheimer's disease	0.000105	0.0266	CrCbGaD
Clomipramine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000105	0.00058	CcSEcCtD
Clomipramine—Hallucination—Rivastigmine—Alzheimer's disease	0.000105	0.000579	CcSEcCtD
Clomipramine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000105	0.000579	CcSEcCtD
Clomipramine—Alopecia—Donepezil—Alzheimer's disease	0.000105	0.000578	CcSEcCtD
Clomipramine—Trifluoperazine—HTR6—Alzheimer's disease	0.000105	0.0265	CrCbGaD
Clomipramine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000105	0.000577	CcSEcCtD
Clomipramine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000104	0.000574	CcSEcCtD
Clomipramine—Mental disorder—Donepezil—Alzheimer's disease	0.000104	0.000573	CcSEcCtD
Clomipramine—Visual impairment—Memantine—Alzheimer's disease	0.000104	0.000573	CcSEcCtD
Clomipramine—Perphenazine—HTR6—Alzheimer's disease	0.000104	0.0262	CrCbGaD
Clomipramine—Anorexia—Galantamine—Alzheimer's disease	0.000104	0.000572	CcSEcCtD
Clomipramine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000104	0.000571	CcSEcCtD
Clomipramine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000103	0.00057	CcSEcCtD
Clomipramine—Malnutrition—Donepezil—Alzheimer's disease	0.000103	0.00057	CcSEcCtD
Clomipramine—Flatulence—Donepezil—Alzheimer's disease	0.000102	0.000562	CcSEcCtD
Clomipramine—Hypotension—Galantamine—Alzheimer's disease	0.000102	0.000561	CcSEcCtD
Clomipramine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000102	0.00056	CcSEcCtD
Clomipramine—Tension—Donepezil—Alzheimer's disease	0.000102	0.000559	CcSEcCtD
Clomipramine—Dysgeusia—Donepezil—Alzheimer's disease	0.000101	0.000558	CcSEcCtD
Clomipramine—Eye disorder—Memantine—Alzheimer's disease	0.000101	0.000555	CcSEcCtD
Clomipramine—Tinnitus—Memantine—Alzheimer's disease	0.000101	0.000554	CcSEcCtD
Clomipramine—Nervousness—Donepezil—Alzheimer's disease	0.0001	0.000553	CcSEcCtD
Clomipramine—Flushing—Memantine—Alzheimer's disease	0.0001	0.000552	CcSEcCtD
Clomipramine—Cardiac disorder—Memantine—Alzheimer's disease	0.0001	0.000552	CcSEcCtD
Clomipramine—Back pain—Donepezil—Alzheimer's disease	0.0001	0.000551	CcSEcCtD
Clomipramine—Muscle spasms—Donepezil—Alzheimer's disease	9.95e-05	0.000548	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	9.93e-05	0.000547	CcSEcCtD
Clomipramine—Eye disorder—Rivastigmine—Alzheimer's disease	9.86e-05	0.000543	CcSEcCtD
Clomipramine—Insomnia—Galantamine—Alzheimer's disease	9.85e-05	0.000543	CcSEcCtD
Clomipramine—Tinnitus—Rivastigmine—Alzheimer's disease	9.84e-05	0.000542	CcSEcCtD
Clomipramine—Cardiac disorder—Rivastigmine—Alzheimer's disease	9.8e-05	0.00054	CcSEcCtD
Clomipramine—Flushing—Rivastigmine—Alzheimer's disease	9.8e-05	0.00054	CcSEcCtD
Clomipramine—Angiopathy—Memantine—Alzheimer's disease	9.79e-05	0.000539	CcSEcCtD
Clomipramine—Paraesthesia—Galantamine—Alzheimer's disease	9.78e-05	0.000539	CcSEcCtD
Clomipramine—Vision blurred—Donepezil—Alzheimer's disease	9.75e-05	0.000537	CcSEcCtD
Clomipramine—Immune system disorder—Memantine—Alzheimer's disease	9.75e-05	0.000537	CcSEcCtD
Clomipramine—Mediastinal disorder—Memantine—Alzheimer's disease	9.72e-05	0.000536	CcSEcCtD
Clomipramine—Tremor—Donepezil—Alzheimer's disease	9.69e-05	0.000534	CcSEcCtD
Clomipramine—Somnolence—Galantamine—Alzheimer's disease	9.68e-05	0.000533	CcSEcCtD
Clomipramine—Chills—Memantine—Alzheimer's disease	9.68e-05	0.000533	CcSEcCtD
Clomipramine—Arrhythmia—Memantine—Alzheimer's disease	9.64e-05	0.000531	CcSEcCtD
Clomipramine—Ill-defined disorder—Donepezil—Alzheimer's disease	9.6e-05	0.000529	CcSEcCtD
Clomipramine—Dyspepsia—Galantamine—Alzheimer's disease	9.59e-05	0.000528	CcSEcCtD
Clomipramine—Angiopathy—Rivastigmine—Alzheimer's disease	9.58e-05	0.000528	CcSEcCtD
Clomipramine—Anaemia—Donepezil—Alzheimer's disease	9.56e-05	0.000527	CcSEcCtD
Clomipramine—Alopecia—Memantine—Alzheimer's disease	9.53e-05	0.000525	CcSEcCtD
Clomipramine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	9.51e-05	0.000524	CcSEcCtD
Clomipramine—Agitation—Donepezil—Alzheimer's disease	9.51e-05	0.000524	CcSEcCtD
Clomipramine—Chills—Rivastigmine—Alzheimer's disease	9.47e-05	0.000522	CcSEcCtD
Clomipramine—Decreased appetite—Galantamine—Alzheimer's disease	9.47e-05	0.000522	CcSEcCtD
Clomipramine—Mental disorder—Memantine—Alzheimer's disease	9.45e-05	0.000521	CcSEcCtD
Clomipramine—Arrhythmia—Rivastigmine—Alzheimer's disease	9.43e-05	0.000519	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	9.41e-05	0.000518	CcSEcCtD
Clomipramine—Malnutrition—Memantine—Alzheimer's disease	9.39e-05	0.000517	CcSEcCtD
Clomipramine—Fatigue—Galantamine—Alzheimer's disease	9.39e-05	0.000517	CcSEcCtD
Clomipramine—Malaise—Donepezil—Alzheimer's disease	9.33e-05	0.000514	CcSEcCtD
Clomipramine—Alopecia—Rivastigmine—Alzheimer's disease	9.33e-05	0.000514	CcSEcCtD
Clomipramine—Constipation—Galantamine—Alzheimer's disease	9.32e-05	0.000513	CcSEcCtD
Clomipramine—Vertigo—Donepezil—Alzheimer's disease	9.29e-05	0.000512	CcSEcCtD
Clomipramine—Syncope—Donepezil—Alzheimer's disease	9.28e-05	0.000511	CcSEcCtD
Clomipramine—Flatulence—Memantine—Alzheimer's disease	9.26e-05	0.00051	CcSEcCtD
Clomipramine—Mental disorder—Rivastigmine—Alzheimer's disease	9.25e-05	0.000509	CcSEcCtD
Clomipramine—Tension—Memantine—Alzheimer's disease	9.22e-05	0.000508	CcSEcCtD
Clomipramine—Dysgeusia—Memantine—Alzheimer's disease	9.2e-05	0.000507	CcSEcCtD
Clomipramine—Malnutrition—Rivastigmine—Alzheimer's disease	9.19e-05	0.000506	CcSEcCtD
Clomipramine—Chlorpromazine—CALM1—Alzheimer's disease	9.14e-05	0.0231	CrCbGaD
Clomipramine—Nervousness—Memantine—Alzheimer's disease	9.12e-05	0.000503	CcSEcCtD
Clomipramine—Loss of consciousness—Donepezil—Alzheimer's disease	9.09e-05	0.000501	CcSEcCtD
Clomipramine—Back pain—Memantine—Alzheimer's disease	9.09e-05	0.0005	CcSEcCtD
Clomipramine—Flatulence—Rivastigmine—Alzheimer's disease	9.05e-05	0.000499	CcSEcCtD
Clomipramine—Cough—Donepezil—Alzheimer's disease	9.03e-05	0.000497	CcSEcCtD
Clomipramine—Tension—Rivastigmine—Alzheimer's disease	9.02e-05	0.000497	CcSEcCtD
Clomipramine—Dysgeusia—Rivastigmine—Alzheimer's disease	9e-05	0.000496	CcSEcCtD
Clomipramine—Feeling abnormal—Galantamine—Alzheimer's disease	8.98e-05	0.000495	CcSEcCtD
Clomipramine—Convulsion—Donepezil—Alzheimer's disease	8.96e-05	0.000494	CcSEcCtD
Clomipramine—Hypertension—Donepezil—Alzheimer's disease	8.93e-05	0.000492	CcSEcCtD
Clomipramine—Nervousness—Rivastigmine—Alzheimer's disease	8.92e-05	0.000492	CcSEcCtD
Clomipramine—Gastrointestinal pain—Galantamine—Alzheimer's disease	8.91e-05	0.000491	CcSEcCtD
Clomipramine—Back pain—Rivastigmine—Alzheimer's disease	8.89e-05	0.00049	CcSEcCtD
Clomipramine—Vision blurred—Memantine—Alzheimer's disease	8.85e-05	0.000488	CcSEcCtD
Clomipramine—Muscle spasms—Rivastigmine—Alzheimer's disease	8.83e-05	0.000487	CcSEcCtD
Clomipramine—Arthralgia—Donepezil—Alzheimer's disease	8.81e-05	0.000485	CcSEcCtD
Clomipramine—Myalgia—Donepezil—Alzheimer's disease	8.81e-05	0.000485	CcSEcCtD
Clomipramine—Chest pain—Donepezil—Alzheimer's disease	8.81e-05	0.000485	CcSEcCtD
Clomipramine—Tremor—Memantine—Alzheimer's disease	8.8e-05	0.000485	CcSEcCtD
Clomipramine—Anxiety—Donepezil—Alzheimer's disease	8.78e-05	0.000483	CcSEcCtD
Clomipramine—Ill-defined disorder—Memantine—Alzheimer's disease	8.71e-05	0.00048	CcSEcCtD
Clomipramine—Discomfort—Donepezil—Alzheimer's disease	8.7e-05	0.000479	CcSEcCtD
Clomipramine—Anaemia—Memantine—Alzheimer's disease	8.68e-05	0.000478	CcSEcCtD
Clomipramine—Vision blurred—Rivastigmine—Alzheimer's disease	8.66e-05	0.000477	CcSEcCtD
Clomipramine—Agitation—Memantine—Alzheimer's disease	8.63e-05	0.000475	CcSEcCtD
Clomipramine—Dry mouth—Donepezil—Alzheimer's disease	8.61e-05	0.000474	CcSEcCtD
Clomipramine—Abdominal pain—Galantamine—Alzheimer's disease	8.61e-05	0.000474	CcSEcCtD
Clomipramine—Body temperature increased—Galantamine—Alzheimer's disease	8.61e-05	0.000474	CcSEcCtD
Clomipramine—Tremor—Rivastigmine—Alzheimer's disease	8.61e-05	0.000474	CcSEcCtD
Clomipramine—ABCB1—brain—Alzheimer's disease	8.6e-05	0.00177	CbGeAlD
Clomipramine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	8.53e-05	0.00047	CcSEcCtD
Clomipramine—Confusional state—Donepezil—Alzheimer's disease	8.51e-05	0.000469	CcSEcCtD
Clomipramine—Anaemia—Rivastigmine—Alzheimer's disease	8.49e-05	0.000468	CcSEcCtD
Clomipramine—Malaise—Memantine—Alzheimer's disease	8.47e-05	0.000467	CcSEcCtD
Clomipramine—Agitation—Rivastigmine—Alzheimer's disease	8.44e-05	0.000465	CcSEcCtD
Clomipramine—Oedema—Donepezil—Alzheimer's disease	8.44e-05	0.000465	CcSEcCtD
Clomipramine—Vertigo—Memantine—Alzheimer's disease	8.44e-05	0.000465	CcSEcCtD
Clomipramine—Syncope—Memantine—Alzheimer's disease	8.42e-05	0.000464	CcSEcCtD
Clomipramine—Leukopenia—Memantine—Alzheimer's disease	8.41e-05	0.000463	CcSEcCtD
Clomipramine—Triflupromazine—BCHE—Alzheimer's disease	8.38e-05	0.0211	CrCbGaD
Clomipramine—Shock—Donepezil—Alzheimer's disease	8.31e-05	0.000458	CcSEcCtD
Clomipramine—Palpitations—Memantine—Alzheimer's disease	8.3e-05	0.000457	CcSEcCtD
Clomipramine—Malaise—Rivastigmine—Alzheimer's disease	8.29e-05	0.000456	CcSEcCtD
Clomipramine—Nervous system disorder—Donepezil—Alzheimer's disease	8.28e-05	0.000456	CcSEcCtD
Clomipramine—Thrombocytopenia—Donepezil—Alzheimer's disease	8.27e-05	0.000455	CcSEcCtD
Clomipramine—Vertigo—Rivastigmine—Alzheimer's disease	8.26e-05	0.000455	CcSEcCtD
Clomipramine—Loss of consciousness—Memantine—Alzheimer's disease	8.26e-05	0.000455	CcSEcCtD
Clomipramine—Syncope—Rivastigmine—Alzheimer's disease	8.24e-05	0.000454	CcSEcCtD
Clomipramine—Chlorpromazine—HTR6—Alzheimer's disease	8.24e-05	0.0208	CrCbGaD
Clomipramine—Imipramine—HTR6—Alzheimer's disease	8.2e-05	0.0207	CrCbGaD
Clomipramine—Cough—Memantine—Alzheimer's disease	8.2e-05	0.000451	CcSEcCtD
Clomipramine—Hyperhidrosis—Donepezil—Alzheimer's disease	8.16e-05	0.00045	CcSEcCtD
Clomipramine—Amitriptyline—HTR6—Alzheimer's disease	8.15e-05	0.0206	CrCbGaD
Clomipramine—Convulsion—Memantine—Alzheimer's disease	8.14e-05	0.000448	CcSEcCtD
Clomipramine—Palpitations—Rivastigmine—Alzheimer's disease	8.12e-05	0.000447	CcSEcCtD
Clomipramine—Hypertension—Memantine—Alzheimer's disease	8.11e-05	0.000447	CcSEcCtD
Clomipramine—Loss of consciousness—Rivastigmine—Alzheimer's disease	8.08e-05	0.000445	CcSEcCtD
Clomipramine—Anorexia—Donepezil—Alzheimer's disease	8.05e-05	0.000443	CcSEcCtD
Clomipramine—Hypersensitivity—Galantamine—Alzheimer's disease	8.03e-05	0.000442	CcSEcCtD
Clomipramine—Cough—Rivastigmine—Alzheimer's disease	8.02e-05	0.000442	CcSEcCtD
Clomipramine—Arthralgia—Memantine—Alzheimer's disease	8e-05	0.00044	CcSEcCtD
Clomipramine—Chest pain—Memantine—Alzheimer's disease	8e-05	0.00044	CcSEcCtD
Clomipramine—Myalgia—Memantine—Alzheimer's disease	8e-05	0.00044	CcSEcCtD
Clomipramine—Anxiety—Memantine—Alzheimer's disease	7.97e-05	0.000439	CcSEcCtD
Clomipramine—Convulsion—Rivastigmine—Alzheimer's disease	7.96e-05	0.000439	CcSEcCtD
Clomipramine—Hypertension—Rivastigmine—Alzheimer's disease	7.93e-05	0.000437	CcSEcCtD
Clomipramine—Discomfort—Memantine—Alzheimer's disease	7.9e-05	0.000435	CcSEcCtD
Clomipramine—Hypotension—Donepezil—Alzheimer's disease	7.89e-05	0.000435	CcSEcCtD
Clomipramine—Myalgia—Rivastigmine—Alzheimer's disease	7.82e-05	0.000431	CcSEcCtD
Clomipramine—Chest pain—Rivastigmine—Alzheimer's disease	7.82e-05	0.000431	CcSEcCtD
Clomipramine—Arthralgia—Rivastigmine—Alzheimer's disease	7.82e-05	0.000431	CcSEcCtD
Clomipramine—Dry mouth—Memantine—Alzheimer's disease	7.82e-05	0.000431	CcSEcCtD
Clomipramine—Asthenia—Galantamine—Alzheimer's disease	7.82e-05	0.000431	CcSEcCtD
Clomipramine—Anxiety—Rivastigmine—Alzheimer's disease	7.8e-05	0.000429	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	7.77e-05	0.000428	CcSEcCtD
Clomipramine—Confusional state—Memantine—Alzheimer's disease	7.73e-05	0.000426	CcSEcCtD
Clomipramine—Discomfort—Rivastigmine—Alzheimer's disease	7.73e-05	0.000426	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	7.69e-05	0.000424	CcSEcCtD
Clomipramine—Oedema—Memantine—Alzheimer's disease	7.67e-05	0.000422	CcSEcCtD
Clomipramine—Dry mouth—Rivastigmine—Alzheimer's disease	7.65e-05	0.000421	CcSEcCtD
Clomipramine—Insomnia—Donepezil—Alzheimer's disease	7.64e-05	0.000421	CcSEcCtD
Clomipramine—Paraesthesia—Donepezil—Alzheimer's disease	7.58e-05	0.000418	CcSEcCtD
Clomipramine—Confusional state—Rivastigmine—Alzheimer's disease	7.56e-05	0.000417	CcSEcCtD
Clomipramine—Shock—Memantine—Alzheimer's disease	7.54e-05	0.000415	CcSEcCtD
Clomipramine—Dyspnoea—Donepezil—Alzheimer's disease	7.53e-05	0.000415	CcSEcCtD
Clomipramine—Nervous system disorder—Memantine—Alzheimer's disease	7.52e-05	0.000414	CcSEcCtD
Clomipramine—Somnolence—Donepezil—Alzheimer's disease	7.51e-05	0.000413	CcSEcCtD
Clomipramine—Thrombocytopenia—Memantine—Alzheimer's disease	7.51e-05	0.000413	CcSEcCtD
Clomipramine—Oedema—Rivastigmine—Alzheimer's disease	7.5e-05	0.000413	CcSEcCtD
Clomipramine—Tachycardia—Memantine—Alzheimer's disease	7.48e-05	0.000412	CcSEcCtD
Clomipramine—Diarrhoea—Galantamine—Alzheimer's disease	7.45e-05	0.000411	CcSEcCtD
Clomipramine—Skin disorder—Memantine—Alzheimer's disease	7.45e-05	0.00041	CcSEcCtD
Clomipramine—Dyspepsia—Donepezil—Alzheimer's disease	7.43e-05	0.000409	CcSEcCtD
Clomipramine—Hyperhidrosis—Memantine—Alzheimer's disease	7.41e-05	0.000408	CcSEcCtD
Clomipramine—Shock—Rivastigmine—Alzheimer's disease	7.38e-05	0.000406	CcSEcCtD
Clomipramine—Nervous system disorder—Rivastigmine—Alzheimer's disease	7.35e-05	0.000405	CcSEcCtD
Clomipramine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	7.34e-05	0.000404	CcSEcCtD
Clomipramine—Decreased appetite—Donepezil—Alzheimer's disease	7.34e-05	0.000404	CcSEcCtD
Clomipramine—Tachycardia—Rivastigmine—Alzheimer's disease	7.32e-05	0.000403	CcSEcCtD
Clomipramine—Anorexia—Memantine—Alzheimer's disease	7.31e-05	0.000403	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	7.29e-05	0.000402	CcSEcCtD
Clomipramine—Skin disorder—Rivastigmine—Alzheimer's disease	7.28e-05	0.000401	CcSEcCtD
Clomipramine—Fatigue—Donepezil—Alzheimer's disease	7.28e-05	0.000401	CcSEcCtD
Clomipramine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	7.25e-05	0.000399	CcSEcCtD
Clomipramine—Cyamemazine—HTR2A—Alzheimer's disease	7.24e-05	0.0183	CrCbGaD
Clomipramine—Pain—Donepezil—Alzheimer's disease	7.22e-05	0.000398	CcSEcCtD
Clomipramine—Constipation—Donepezil—Alzheimer's disease	7.22e-05	0.000398	CcSEcCtD
Clomipramine—Dizziness—Galantamine—Alzheimer's disease	7.2e-05	0.000397	CcSEcCtD
Clomipramine—Hypotension—Memantine—Alzheimer's disease	7.16e-05	0.000395	CcSEcCtD
Clomipramine—Anorexia—Rivastigmine—Alzheimer's disease	7.15e-05	0.000394	CcSEcCtD
Clomipramine—Hypotension—Rivastigmine—Alzheimer's disease	7.01e-05	0.000386	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	6.98e-05	0.000385	CcSEcCtD
Clomipramine—Feeling abnormal—Donepezil—Alzheimer's disease	6.96e-05	0.000383	CcSEcCtD
Clomipramine—Insomnia—Memantine—Alzheimer's disease	6.93e-05	0.000382	CcSEcCtD
Clomipramine—Vomiting—Galantamine—Alzheimer's disease	6.93e-05	0.000382	CcSEcCtD
Clomipramine—Gastrointestinal pain—Donepezil—Alzheimer's disease	6.9e-05	0.00038	CcSEcCtD
Clomipramine—Paraesthesia—Memantine—Alzheimer's disease	6.88e-05	0.000379	CcSEcCtD
Clomipramine—Rash—Galantamine—Alzheimer's disease	6.87e-05	0.000378	CcSEcCtD
Clomipramine—Dermatitis—Galantamine—Alzheimer's disease	6.86e-05	0.000378	CcSEcCtD
Clomipramine—Dyspnoea—Memantine—Alzheimer's disease	6.83e-05	0.000376	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	6.83e-05	0.000376	CcSEcCtD
Clomipramine—Headache—Galantamine—Alzheimer's disease	6.82e-05	0.000376	CcSEcCtD
Clomipramine—Somnolence—Memantine—Alzheimer's disease	6.81e-05	0.000375	CcSEcCtD
Clomipramine—Insomnia—Rivastigmine—Alzheimer's disease	6.78e-05	0.000374	CcSEcCtD
Clomipramine—Dyspepsia—Memantine—Alzheimer's disease	6.75e-05	0.000372	CcSEcCtD
Clomipramine—Paraesthesia—Rivastigmine—Alzheimer's disease	6.73e-05	0.000371	CcSEcCtD
Clomipramine—Urticaria—Donepezil—Alzheimer's disease	6.71e-05	0.000369	CcSEcCtD
Clomipramine—Dyspnoea—Rivastigmine—Alzheimer's disease	6.69e-05	0.000368	CcSEcCtD
Clomipramine—Abdominal pain—Donepezil—Alzheimer's disease	6.67e-05	0.000368	CcSEcCtD
Clomipramine—Body temperature increased—Donepezil—Alzheimer's disease	6.67e-05	0.000368	CcSEcCtD
Clomipramine—Somnolence—Rivastigmine—Alzheimer's disease	6.67e-05	0.000367	CcSEcCtD
Clomipramine—Decreased appetite—Memantine—Alzheimer's disease	6.66e-05	0.000367	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Memantine—Alzheimer's disease	6.62e-05	0.000365	CcSEcCtD
Clomipramine—Fatigue—Memantine—Alzheimer's disease	6.61e-05	0.000364	CcSEcCtD
Clomipramine—Dyspepsia—Rivastigmine—Alzheimer's disease	6.6e-05	0.000364	CcSEcCtD
Clomipramine—Constipation—Memantine—Alzheimer's disease	6.56e-05	0.000361	CcSEcCtD
Clomipramine—Pain—Memantine—Alzheimer's disease	6.56e-05	0.000361	CcSEcCtD
Clomipramine—Decreased appetite—Rivastigmine—Alzheimer's disease	6.52e-05	0.000359	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	6.47e-05	0.000357	CcSEcCtD
Clomipramine—Nausea—Galantamine—Alzheimer's disease	6.47e-05	0.000356	CcSEcCtD
Clomipramine—Fatigue—Rivastigmine—Alzheimer's disease	6.47e-05	0.000356	CcSEcCtD
Clomipramine—Pain—Rivastigmine—Alzheimer's disease	6.41e-05	0.000353	CcSEcCtD
Clomipramine—Constipation—Rivastigmine—Alzheimer's disease	6.41e-05	0.000353	CcSEcCtD
Clomipramine—Feeling abnormal—Memantine—Alzheimer's disease	6.32e-05	0.000348	CcSEcCtD
Clomipramine—Gastrointestinal pain—Memantine—Alzheimer's disease	6.27e-05	0.000345	CcSEcCtD
Clomipramine—Hypersensitivity—Donepezil—Alzheimer's disease	6.22e-05	0.000343	CcSEcCtD
Clomipramine—Feeling abnormal—Rivastigmine—Alzheimer's disease	6.18e-05	0.00034	CcSEcCtD
Clomipramine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	6.13e-05	0.000338	CcSEcCtD
Clomipramine—Chlorphenamine—SLC6A4—Alzheimer's disease	6.12e-05	0.0155	CrCbGaD
Clomipramine—Urticaria—Memantine—Alzheimer's disease	6.09e-05	0.000335	CcSEcCtD
Clomipramine—Abdominal pain—Memantine—Alzheimer's disease	6.06e-05	0.000334	CcSEcCtD
Clomipramine—Body temperature increased—Memantine—Alzheimer's disease	6.06e-05	0.000334	CcSEcCtD
Clomipramine—Asthenia—Donepezil—Alzheimer's disease	6.06e-05	0.000334	CcSEcCtD
Clomipramine—Pruritus—Donepezil—Alzheimer's disease	5.97e-05	0.000329	CcSEcCtD
Clomipramine—Urticaria—Rivastigmine—Alzheimer's disease	5.96e-05	0.000328	CcSEcCtD
Clomipramine—Abdominal pain—Rivastigmine—Alzheimer's disease	5.93e-05	0.000327	CcSEcCtD
Clomipramine—Body temperature increased—Rivastigmine—Alzheimer's disease	5.93e-05	0.000327	CcSEcCtD
Clomipramine—Diarrhoea—Donepezil—Alzheimer's disease	5.78e-05	0.000318	CcSEcCtD
Clomipramine—Hypersensitivity—Memantine—Alzheimer's disease	5.65e-05	0.000311	CcSEcCtD
Clomipramine—Dizziness—Donepezil—Alzheimer's disease	5.58e-05	0.000308	CcSEcCtD
Clomipramine—Hypersensitivity—Rivastigmine—Alzheimer's disease	5.53e-05	0.000304	CcSEcCtD
Clomipramine—Asthenia—Memantine—Alzheimer's disease	5.5e-05	0.000303	CcSEcCtD
Clomipramine—Pruritus—Memantine—Alzheimer's disease	5.42e-05	0.000299	CcSEcCtD
Clomipramine—Asthenia—Rivastigmine—Alzheimer's disease	5.38e-05	0.000296	CcSEcCtD
Clomipramine—Vomiting—Donepezil—Alzheimer's disease	5.37e-05	0.000296	CcSEcCtD
Clomipramine—Rash—Donepezil—Alzheimer's disease	5.32e-05	0.000293	CcSEcCtD
Clomipramine—Dermatitis—Donepezil—Alzheimer's disease	5.32e-05	0.000293	CcSEcCtD
Clomipramine—Pruritus—Rivastigmine—Alzheimer's disease	5.31e-05	0.000292	CcSEcCtD
Clomipramine—Headache—Donepezil—Alzheimer's disease	5.29e-05	0.000291	CcSEcCtD
Clomipramine—Diarrhoea—Memantine—Alzheimer's disease	5.24e-05	0.000289	CcSEcCtD
Clomipramine—Diarrhoea—Rivastigmine—Alzheimer's disease	5.13e-05	0.000283	CcSEcCtD
Clomipramine—Dizziness—Memantine—Alzheimer's disease	5.07e-05	0.000279	CcSEcCtD
Clomipramine—Carbinoxamine—CYP2D6—Alzheimer's disease	5.06e-05	0.0128	CrCbGaD
Clomipramine—Nausea—Donepezil—Alzheimer's disease	5.01e-05	0.000276	CcSEcCtD
Clomipramine—Dizziness—Rivastigmine—Alzheimer's disease	4.96e-05	0.000273	CcSEcCtD
Clomipramine—Vomiting—Memantine—Alzheimer's disease	4.87e-05	0.000268	CcSEcCtD
Clomipramine—Rash—Memantine—Alzheimer's disease	4.83e-05	0.000266	CcSEcCtD
Clomipramine—Dermatitis—Memantine—Alzheimer's disease	4.83e-05	0.000266	CcSEcCtD
Clomipramine—Headache—Memantine—Alzheimer's disease	4.8e-05	0.000265	CcSEcCtD
Clomipramine—Vomiting—Rivastigmine—Alzheimer's disease	4.77e-05	0.000263	CcSEcCtD
Clomipramine—Rash—Rivastigmine—Alzheimer's disease	4.73e-05	0.00026	CcSEcCtD
Clomipramine—Dermatitis—Rivastigmine—Alzheimer's disease	4.72e-05	0.00026	CcSEcCtD
Clomipramine—Headache—Rivastigmine—Alzheimer's disease	4.7e-05	0.000259	CcSEcCtD
Clomipramine—Acepromazine—HTR2A—Alzheimer's disease	4.65e-05	0.0117	CrCbGaD
Clomipramine—Nortriptyline—PTGS1—Alzheimer's disease	4.64e-05	0.0117	CrCbGaD
Clomipramine—Nausea—Memantine—Alzheimer's disease	4.55e-05	0.000251	CcSEcCtD
Clomipramine—Thioproperazine—HTR2A—Alzheimer's disease	4.54e-05	0.0115	CrCbGaD
Clomipramine—Nortriptyline—SLC6A4—Alzheimer's disease	4.49e-05	0.0113	CrCbGaD
Clomipramine—Pipotiazine—HTR2A—Alzheimer's disease	4.47e-05	0.0113	CrCbGaD
Clomipramine—Nausea—Rivastigmine—Alzheimer's disease	4.45e-05	0.000245	CcSEcCtD
Clomipramine—Chlorphenamine—CYP2D6—Alzheimer's disease	4.3e-05	0.0109	CrCbGaD
Clomipramine—Trimipramine—SLC6A4—Alzheimer's disease	4.23e-05	0.0107	CrCbGaD
Clomipramine—Pipotiazine—CYP2D6—Alzheimer's disease	4.09e-05	0.0103	CrCbGaD
Clomipramine—Chlorpromazine—BCHE—Alzheimer's disease	4.04e-05	0.0102	CrCbGaD
Clomipramine—Doxepin—SLC6A4—Alzheimer's disease	4.03e-05	0.0102	CrCbGaD
Clomipramine—Prochlorperazine—CYP2D6—Alzheimer's disease	3.91e-05	0.00986	CrCbGaD
Clomipramine—Propiomazine—HTR2A—Alzheimer's disease	3.72e-05	0.00938	CrCbGaD
Clomipramine—Desipramine—SLC6A4—Alzheimer's disease	3.7e-05	0.00934	CrCbGaD
Clomipramine—Chlorprothixene—HTR2A—Alzheimer's disease	3.52e-05	0.00888	CrCbGaD
Clomipramine—Diazepam—PTGS1—Alzheimer's disease	3.51e-05	0.00885	CrCbGaD
Clomipramine—Nortriptyline—HTR2A—Alzheimer's disease	3.45e-05	0.00872	CrCbGaD
Clomipramine—Thioridazine—HTR2A—Alzheimer's disease	3.33e-05	0.0084	CrCbGaD
Clomipramine—Trimipramine—HTR2A—Alzheimer's disease	3.25e-05	0.00821	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—Alzheimer's disease	3.18e-05	0.00802	CrCbGaD
Clomipramine—Nortriptyline—CYP2D6—Alzheimer's disease	3.16e-05	0.00797	CrCbGaD
Clomipramine—Imipramine—SLC6A4—Alzheimer's disease	3.14e-05	0.00792	CrCbGaD
Clomipramine—Promethazine—HTR2A—Alzheimer's disease	3.13e-05	0.0079	CrCbGaD
Clomipramine—Amitriptyline—SLC6A4—Alzheimer's disease	3.12e-05	0.00787	CrCbGaD
Clomipramine—Doxepin—HTR2A—Alzheimer's disease	3.1e-05	0.00782	CrCbGaD
Clomipramine—Trifluoperazine—HTR2A—Alzheimer's disease	3.09e-05	0.0078	CrCbGaD
Clomipramine—Perphenazine—HTR2A—Alzheimer's disease	3.06e-05	0.00771	CrCbGaD
Clomipramine—Thioridazine—CYP2D6—Alzheimer's disease	3.04e-05	0.00768	CrCbGaD
Clomipramine—Trimipramine—CYP2D6—Alzheimer's disease	2.97e-05	0.00751	CrCbGaD
Clomipramine—Methotrimeprazine—CYP2D6—Alzheimer's disease	2.91e-05	0.00734	CrCbGaD
Clomipramine—Promethazine—CYP2D6—Alzheimer's disease	2.86e-05	0.00723	CrCbGaD
Clomipramine—Desipramine—HTR2A—Alzheimer's disease	2.84e-05	0.00718	CrCbGaD
Clomipramine—Doxepin—CYP2D6—Alzheimer's disease	2.83e-05	0.00715	CrCbGaD
Clomipramine—Perphenazine—CYP2D6—Alzheimer's disease	2.79e-05	0.00705	CrCbGaD
Clomipramine—Promazine—HTR2A—Alzheimer's disease	2.75e-05	0.00695	CrCbGaD
Clomipramine—Desipramine—CYP2D6—Alzheimer's disease	2.6e-05	0.00656	CrCbGaD
Clomipramine—Chlorpromazine—HTR2A—Alzheimer's disease	2.42e-05	0.00612	CrCbGaD
Clomipramine—Imipramine—HTR2A—Alzheimer's disease	2.41e-05	0.00609	CrCbGaD
Clomipramine—Amitriptyline—HTR2A—Alzheimer's disease	2.4e-05	0.00605	CrCbGaD
Clomipramine—Chlorpromazine—CYP2D6—Alzheimer's disease	2.22e-05	0.0056	CrCbGaD
Clomipramine—Imipramine—CYP2D6—Alzheimer's disease	2.21e-05	0.00557	CrCbGaD
Clomipramine—Amitriptyline—CYP2D6—Alzheimer's disease	2.19e-05	0.00553	CrCbGaD
Clomipramine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	4.53e-06	8.73e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—LPL—Alzheimer's disease	4.52e-06	8.72e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CASP3—Alzheimer's disease	4.51e-06	8.71e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	4.51e-06	8.69e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF1—Alzheimer's disease	4.5e-06	8.68e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—Alzheimer's disease	4.48e-06	8.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	4.48e-06	8.64e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	4.46e-06	8.61e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	4.41e-06	8.51e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	4.41e-06	8.51e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	4.41e-06	8.5e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—BCHE—Alzheimer's disease	4.35e-06	8.4e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	4.33e-06	8.36e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	4.31e-06	8.32e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—GSK3B—Alzheimer's disease	4.3e-06	8.3e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	4.28e-06	8.26e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CREB1—Alzheimer's disease	4.27e-06	8.24e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—INS—Alzheimer's disease	4.24e-06	8.19e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	4.21e-06	8.12e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	4.18e-06	8.06e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	4.15e-06	8.01e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK8—Alzheimer's disease	4.15e-06	8e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AKT1—Alzheimer's disease	4.14e-06	7.98e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.13e-06	7.97e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.12e-06	7.94e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	4.11e-06	7.93e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	4.11e-06	7.92e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.1e-06	7.92e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.09e-06	7.89e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	4.08e-06	7.87e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NOS3—Alzheimer's disease	4.08e-06	7.87e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	4.08e-06	7.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	4.07e-06	7.85e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.04e-06	7.79e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	4.02e-06	7.76e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	4.01e-06	7.73e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	4.01e-06	7.73e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.99e-06	7.7e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.98e-06	7.68e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—Alzheimer's disease	3.98e-06	7.68e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	3.97e-06	7.66e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.97e-06	7.66e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.97e-06	7.66e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.94e-06	7.61e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	3.94e-06	7.6e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	3.93e-06	7.59e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARGC1A—Alzheimer's disease	3.92e-06	7.56e-05	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AKT1—Alzheimer's disease	3.92e-06	7.56e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—HMOX1—Alzheimer's disease	3.9e-06	7.52e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	3.87e-06	7.47e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—Alzheimer's disease	3.83e-06	7.39e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	3.83e-06	7.38e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	3.83e-06	7.38e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	3.81e-06	7.35e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.81e-06	7.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	3.8e-06	7.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—Alzheimer's disease	3.79e-06	7.31e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—F2—Alzheimer's disease	3.78e-06	7.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	3.78e-06	7.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	3.75e-06	7.24e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.75e-06	7.24e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	3.74e-06	7.22e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	3.74e-06	7.21e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	3.74e-06	7.21e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	3.72e-06	7.18e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	3.7e-06	7.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	3.67e-06	7.09e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	3.67e-06	7.07e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.66e-06	7.07e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TGFB1—Alzheimer's disease	3.65e-06	7.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	3.58e-06	6.9e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—LPL—Alzheimer's disease	3.57e-06	6.88e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.54e-06	6.83e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	3.52e-06	6.78e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TGFB1—Alzheimer's disease	3.52e-06	6.78e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	3.5e-06	6.75e-05	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AKT1—Alzheimer's disease	3.49e-06	6.74e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	3.49e-06	6.74e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	3.48e-06	6.72e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	3.48e-06	6.72e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	3.48e-06	6.72e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	3.48e-06	6.71e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	3.47e-06	6.7e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CASP3—Alzheimer's disease	3.46e-06	6.68e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	3.45e-06	6.65e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	3.44e-06	6.64e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—Alzheimer's disease	3.44e-06	6.64e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.43e-06	6.62e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	3.42e-06	6.61e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.42e-06	6.59e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	3.41e-06	6.57e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	3.37e-06	6.5e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	3.32e-06	6.41e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	3.31e-06	6.39e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	3.3e-06	6.37e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	3.28e-06	6.33e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	3.28e-06	6.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—INS—Alzheimer's disease	3.24e-06	6.24e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.23e-06	6.24e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.22e-06	6.21e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	3.22e-06	6.21e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.22e-06	6.21e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.21e-06	6.2e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—Alzheimer's disease	3.21e-06	6.19e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.2e-06	6.18e-05	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.19e-06	6.15e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK8—Alzheimer's disease	3.18e-06	6.14e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	3.18e-06	6.13e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.18e-06	6.13e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—Alzheimer's disease	3.17e-06	6.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.17e-06	6.11e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.17e-06	6.11e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	3.16e-06	6.1e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	3.14e-06	6.06e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.14e-06	6.05e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—LPL—Alzheimer's disease	3.12e-06	6.03e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.08e-06	5.94e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.04e-06	5.87e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.02e-06	5.83e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.01e-06	5.82e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—Alzheimer's disease	3.01e-06	5.8e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3e-06	5.79e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CALM1—Alzheimer's disease	3e-06	5.79e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.99e-06	5.77e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—Alzheimer's disease	2.99e-06	5.77e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.99e-06	5.76e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.97e-06	5.74e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CAV1—Alzheimer's disease	2.96e-06	5.71e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.94e-06	5.68e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	2.94e-06	5.67e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.93e-06	5.65e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.92e-06	5.64e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.9e-06	5.6e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.9e-06	5.59e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—Alzheimer's disease	2.89e-06	5.58e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.89e-06	5.57e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.89e-06	5.57e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.88e-06	5.56e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.88e-06	5.55e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.84e-06	5.47e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.83e-06	5.46e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.81e-06	5.43e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.74e-06	5.29e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.74e-06	5.29e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.73e-06	5.26e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.72e-06	5.25e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.71e-06	5.22e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	2.7e-06	5.2e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.69e-06	5.2e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.68e-06	5.18e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.68e-06	5.18e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.68e-06	5.17e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.66e-06	5.14e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.66e-06	5.13e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.65e-06	5.11e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—Alzheimer's disease	2.65e-06	5.11e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.63e-06	5.07e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—Alzheimer's disease	2.62e-06	5.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.62e-06	5.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.61e-06	5.03e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARG—Alzheimer's disease	2.6e-06	5.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.6e-06	5.01e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.59e-06	5.01e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.57e-06	4.97e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—INS—Alzheimer's disease	2.55e-06	4.93e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.55e-06	4.92e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—Alzheimer's disease	2.54e-06	4.9e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.53e-06	4.89e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.53e-06	4.88e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.49e-06	4.81e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.48e-06	4.78e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.47e-06	4.76e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.46e-06	4.75e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.45e-06	4.73e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.45e-06	4.72e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—Alzheimer's disease	2.44e-06	4.72e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.37e-06	4.58e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.34e-06	4.52e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.34e-06	4.51e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.34e-06	4.51e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—INS—Alzheimer's disease	2.29e-06	4.42e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.28e-06	4.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.25e-06	4.33e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NOS3—Alzheimer's disease	2.24e-06	4.32e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—INS—Alzheimer's disease	2.24e-06	4.32e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.23e-06	4.31e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	2.22e-06	4.28e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.21e-06	4.27e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.2e-06	4.24e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.16e-06	4.17e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.15e-06	4.15e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.11e-06	4.08e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.11e-06	4.07e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.1e-06	4.06e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.1e-06	4.05e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.09e-06	4.03e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.07e-06	4e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—Alzheimer's disease	2.05e-06	3.95e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.03e-06	3.93e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.03e-06	3.92e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	2.03e-06	3.92e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.03e-06	3.92e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	2.03e-06	3.91e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.01e-06	3.89e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.01e-06	3.88e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2e-06	3.86e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.99e-06	3.83e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.96e-06	3.79e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.92e-06	3.71e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.88e-06	3.63e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.87e-06	3.62e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.85e-06	3.58e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.85e-06	3.57e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.85e-06	3.57e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.85e-06	3.56e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.84e-06	3.55e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.82e-06	3.51e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.79e-06	3.46e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.79e-06	3.45e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.73e-06	3.34e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.72e-06	3.33e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.71e-06	3.3e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.71e-06	3.3e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.69e-06	3.26e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.63e-06	3.15e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.62e-06	3.12e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.61e-06	3.11e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.6e-06	3.08e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.57e-06	3.03e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.57e-06	3.02e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.5e-06	2.89e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.43e-06	2.76e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.42e-06	2.74e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.41e-06	2.71e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.38e-06	2.66e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.38e-06	2.66e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.3e-06	2.52e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.3e-06	2.51e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	2.49e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.21e-06	2.33e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.2e-06	2.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	2.28e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	2.13e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	2.1e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—Alzheimer's disease	1.03e-06	1.99e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	9.24e-07	1.78e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—Alzheimer's disease	9.02e-07	1.74e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.5e-07	1.64e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	7.2e-07	1.39e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.56e-07	1.07e-05	CbGpPWpGaD
